tradingkey.logo

Clarity Pharmaceuticals Says Cu-64 SAR-Bombesin Safe, Well Tolerated, Effective In Detecting Prostate Cancer

ReutersJun 13, 2025 1:36 PM

- Clarity Pharmaceuticals Ltd CU6.AX:

  • CLARITY PHARMACEUTICALS LTD - CU-64 SAR-BOMBESIN SAFE, WELL TOLERATED, EFFECTIVE IN DETECTING PROSTATE CANCER

  • CLARITY PHARMACEUTICALS LTD - ONLY TWO PARTICIPANTS HAD MILD ADVERSE EVENTS RELATED TO CU-64 SAR-BOMBESIN

  • CLARITY PHARMACEUTICALS LTD - CU-64 SAR-BOMBESIN IDENTIFIED LESIONS IN 35% OF PARTICIPANTS ON SAME-DAY IMAGING

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI